BackPurple Biotech Overview

Purple Biotech Total Assets

Purple Biotech's total assets is $14M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$14.42M

Peer average

Loading

Purple Biotech Total Assets History

Loading

Purple Biotech vs. peers: Total Assets Comparison

Loading

Purple Biotech Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Purple Biotech (PPBT) FAQ

The latest total assets for PPBT is $14M as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Purple Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, PPBT's total assets moved from $0 to $14M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Purple Biotech's operating scale or balance-sheet position.

A total assets figure of $14M for PPBT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PPBT's total assets ($14M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Purple Biotech's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.